Contact Us: 01282 426380
KM Financial Solutions | J&J raises U.S. prices on around two dozen drugs
42973
post-template-default,single,single-post,postid-42973,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

J&J raises U.S. prices on around two dozen drugs

09 Jan J&J raises U.S. prices on around two dozen drugs

Posted at 23:27h in News by
0 Likes
Johnson & Johnson
raised U.S. prices on around two dozen prescription drugs on
Thursday, including the psoriasis treatment Stelara, prostate
cancer drug Zytiga and blood thinner Xarelto, all among its
top-selling products.

No Comments

Sorry, the comment form is closed at this time.